Search for European Projects

Over 40 European Projects Found

Searched on 125080 European Projects

 FINISHED 

Novel Quantum Emitters monolithically grown on Si, Ge and III-V substrates (4PHOTON)

Start date: Jan 1, 2017, End date: Dec 31, 2020,

We propose to forge a partnership between the leading European groups working on the next generation of solid state quantum emitters based on novel growth methods such as Droplet Epitaxy. Future, practical Nano-photonics and Quantum Circuits applications demand semiconductor quantum dots that can be grown on substrates with different lattice parameters (Si, Ge, GaAs), different substrate orientati ...
Read Project

 11

 FINISHED 

Mechanisms of Evasive Resistance in Cancer (MERiC)

Start date: May 1, 2014, End date: Apr 30, 2020,

Cancer is a major health problem due to the failure of current therapies to effectively eradicate the disease. Alternative signaling pathways compensate for a therapeutically targeted pathway, a process referred to as 'evasive resistance'. The identities of the alternative signaling pathways and functional interconnections that underlie evasive resistance remain widely unknown. We propose to integ ...
Read Project

 3

 FINISHED 

OPtimising thERapy to prevent Avoidable hospital admissions in the Multimorbid elderly (OPERAM)

Start date: May 1, 2015, End date: Apr 30, 2020,

Most older adults have multiple chronic diseases (multimorbidity) and multiple medications (polypharmacy). However, multimorbid patients are often excluded from clinical trials and most guidelines address diseases in isolation. Inappropriate drug prescription and poor drug compliance are common and contribute to up to 30% of hospital admissions. OPERAM investigators developed STOPP/START criteria ...
Read Project

 9

 FINISHED 

Imaging the Force of Cancer (FORCE)

Start date: Jan 1, 2016, End date: Dec 31, 2019,

Cancer is the second leading cause of mortality in EU member states with ~90% of all cancer deaths caused by metastatic spread. Despite its significance, measuring metastatic potential as well as potential indicators of therapy efficacy remain unmet clinical challenges. Recently, it has been demonstrated in vitro, that aggressive metastatic cells pull on their surroundings suggesting that metastat ...
Read Project

 18

 FINISHED 

Nanoscale solid-state spin systems in emerging quantum technologies (Spin-NANO)

Start date: Jan 1, 2016, End date: Dec 31, 2019,

...y 14 academic and 7 industrial groups. Network-wide training course in transferable skills will be specially developed and delivered by the Think Ahead (Sheffield), an award winning initiative at the University of Sheffield (award by the Times Higher Education, 2014). Current proposal is designed to advance this multi-disciplinary research field significantly beyond the state-of-the-art, and train ...
Read Project

 11

 FINISHED 

Development of a multi-stakeholder dialogue platform and Think tank to promote innovation with Nature based solutions (ThinkNature)

Start date: Dec 1, 2016, End date: Nov 30, 2019,

Nature-based solutions (NBS) aim to help societies to address a variety of environmental, social and economic challenges in sustainable ways. They are actions which are inspired by and supported by nature. Some involve using and enhancing existing natural solutions to challenges, while others are exploring more novel solutions, for example, based on how non-human organisms and communities cope wit ...
Read Project

 18

 FINISHED 

Deciphering PI3K biology in health and disease (Phd)

Start date: Nov 1, 2015, End date: Oct 31, 2019,

The Phosphoinositide 3-kinase (PI3K) pathway is at the core of multiple fundamental biological processes controlling metabolism, protein synthesis, cell growth, survival, and migration. This inevitably leads to the involvement of the PI3K signalling pathway in a number of different diseases, ranging from inflammation and diabetes to cancer, with PI3K pathway alterations present in almost 80% of hu ...
Read Project

 11

 FINISHED 

Principles of Polarity – Integrating genetic, biophysical and computational approaches to understand cell and tissue polarity (PolarNet)

Start date: Oct 1, 2015, End date: Sep 30, 2019,

The ability of cells to polarize underlies the most basic biological functions such as motility and response to external challenges, but also the formation and maintenance of tissues in a multicellular organism. The importance of cell polarity is underscored by the fact that cell polarity is essential for animal development and is perturbed in disease states such as cancer. Understanding cell pola ...
Read Project

 9

 FINISHED 

The Choice for Europe since Maastricht. Member States' Preferences for Economic and Financial Integration (EMU_SCEUS)

Start date: Jul 1, 2015, End date: Jun 30, 2019,

The Eurozone crisis corroborated the warnings of economists that weak economic policy coordination and loose fiscal oversight would be insufficient to stabilise the monetary union. To prevent a recurrence of the crisis, economists, political actors and the “Blueprint” of the European Commission are asking for the construction of a deep and genuine economic and monetary union with reinforced govern ...
Read Project

 10

 FINISHED 

Demonstrating synergies in combined natural and engineered processes for water treatment systems (AquaNES)

Start date: Jun 1, 2016, End date: May 31, 2019,

The AquaNES project will catalyse innovations in water and wastewater treatment processes and management through improved combinations of natural and engineered components. Among the demonstrated solutions are natural treatment processes such as bank filtration (BF), managed aquifer recharge (MAR) and constructed wetlands (CW) plus engineered pre- and post-treatment options. The project focuses on ...
Read Project

 30

 FINISHED 

Ultra-low dose of IL-2 for the treatment of recently diagnosed type 1 diabetes (DIABIL-2)

Start date: Oct 1, 2012, End date: Mar 31, 2019,

ConceptThe discovery of regulatory T cells (Tregs) has revolutionized our understanding of autoimmune diseases. As T1D is caused by the failure of Tregs to block autoimmune destruction of pancreatic ß-cells, Treg stimulation has the potential to stop the process, preserve ß-cells’ insulin secretion, and likewise prevent or delay disease progression and improve clinical outcome for patients.Backgro ...
Read Project

 7

 FINISHED 

TBVAC2020; Advancing novel and promising TB vaccine candidates from discovery to preclinical and early clinical development (TBVAC2020)

Start date: Jan 1, 2015, End date: Dec 31, 2018,

The TBVAC2020 proposal builds on the highly successful and long-standing collaborations in subsequent EC-FP5-, FP6- and FP7-funded TB vaccine and biomarker projects, but also brings in a large number of new key partners from excellent laboratories from Europe, USA, Asia, Africa and Australia, many of which are global leaders in the TB field. This was initiated by launching an open call for Express ...
Read Project

 49

 FINISHED 

Near-surface Geothermal Resources in the Territory of the Alpine Space (GRETA)

Start date: Dec 16, 2015, End date: Dec 15, 2018,

Description (EN): The Alpine region must tackle rising energy consumption and, accordingly, CO2 emissions reduction, related mostly to heating needs (mainly from residential and tourism sectors). The potential of renewable energy sources to handle this energy requirement has been discussed in some recent studies. However, the opportunity to utilize Near-Surface Geothermal Energy (NS ...
Read Project

 12

 FINISHED 

Personalised Prognostic Tools for Early Psychosis Management (PRONIA)

Start date: Oct 1, 2013, End date: Sep 30, 2018,

Affective and non-affective psychoses have a major negative impact on human society. They account for 6.3% of the global burden of disease and cost €207 billion per year in Europe alone, making them the most expensive brain-related disorders and even more expensive than cardiovascular diseases. This socioeconomic burden is largely caused by two core disease features: onset in adolescence and early ...
Read Project

 13

 FINISHED 

Accelerated Development of Vaccine benefit-risk Collaboration in Europe (ADVANCE)

Start date: Oct 1, 2013, End date: Sep 30, 2018,

Aim: The ADVANCE vision is focused on Timely and Best Evidence on Vaccine Effects. Our mission is to establish a best practice framework to rapidly provide robust data on vaccine benefits and risks to support accelerated decision-making.Approach: To achieve this vision through a public-private partnership, ADVANCE partners 1. establish common grounds and rules for collaboration between public and ...
Read Project

 30

 FINISHED 

Reservoir Computing with Real-time Data for future IT (RECORD-IT)

Start date: Sep 1, 2015, End date: Aug 31, 2018,

The aim of this proposal is to develop an intelligent biocompatible sensing device which detects complex behavioural changes in ion concentrations. The sensor will use wet NOMFETs, coated Si nanowires, self-conjugated polymers, arrays of photocells, flow of lipids. The level of ions will be measured by monitoring changes in the response function of the system. The high sensitivity of the device wi ...
Read Project

 9

 FINISHED 

Human Brain Project Specific Grant Agreement 1 (HBP SGA1)

Start date: Apr 1, 2016, End date: Mar 31, 2018,

Understanding the human brain is one of the greatest scientific challenges of our time. Such an understanding can provide profound insights into our humanity, leading to fundamentally new computing technologies, and transforming the diagnosis and treatment of brain disorders. Modern ICT brings this prospect within reach. The HBP Flagship Initiative (HBP) thus proposes a unique strategy that uses I ...
Read Project

 126

 FINISHED 

Graphene-based disruptive technologies (GrapheneCore1)

Start date: Apr 1, 2016, End date: Mar 31, 2018,

This project is the second in the series of EC-financed parts of the Graphene Flagship. The Graphene Flagship is a 10 year research and innovation endeavour with a total project cost of 1,000,000,000 euros, funded jointly by the European Commission and member states and associated countries. The first part of the Flagship was a 30-month Collaborative Project, Coordination and Support Action (CP-CS ...
Read Project

 158

 FINISHED 

Personalized diagnosis and treatment of hyperinsulinemic hypoglycaemia caused by beta-cell pathology (BETACURE)

Start date: Apr 1, 2014, End date: Mar 31, 2018,

Background:Hyperinsulinaemic hypoglycaemia (HH) is a potentially lethal disease caused by over functioning beta cells derived from the pancreatic islets of Langerhans. Lethal HH and brain damage is a problem especially in infants with congenital HH. Current therapeutic approaches are associated with severe side effects/morbidity (diabetes, exocrine pancreas insufficiency etc.) considered acceptabl ...
Read Project

 17

 FINISHED 

Negotiating early job-insecurity and labour market exclusion in Europe (NEGOTIATE)

Start date: Mar 1, 2015, End date: Feb 28, 2018,

Through an innovative use of four key concepts (resilience, capability, active agency and negotiation) and primary data (life course interviews, vignette experiments), NEGOTIATE will deliver gender-sensitive comparative knowledge about consequences of early job insecurity. We move beyond the state-of-the-art by investigating the linkages across macro, meso and micro levels as mechanisms of early j ...
Read Project

 10

 FINISHED 

Neurobiology and Treatment of Adolescent Female Conduct Disorder: The Central Role of Emotion Processing (FEMNAT-CD)

Start date: Sep 1, 2013, End date: Feb 28, 2018,

Conduct Disorder (CD) and Oppositional Defiant Disorder with symptoms of Conduct Disorder (which is included among the abbreviation “CD” throughout the proposal) has a highly negative impact for the affected individual as well as for families and society. Although the number of females exhibiting serious aggressive behaviours is growing, the majority of studies on aetiology and treatment of CD hav ...
Read Project

 19

 FINISHED 

URBan ANthrpogenic heat FLUX from Earth observation Satellites (URBANFLUXES)

Start date: Jan 1, 2015, End date: Dec 31, 2017,

The main goal of the proposed project URBANFLUXES (URBan ANthrpogenic heat FLUX from Earth observation Satellites) is to investigate the potential of Earth Observation (EO) to retrieve anthropogenic heat fluxes. The main research question addresses whether EO is able to provide reliable estimates of anthropogenic heat flux spatiotemporal distribution, at local and city scales. URBANFLUXES will inv ...
Read Project

 8

 FINISHED 

Molecular basis of the outer membrane permeability (TRANSLOCATION)

Start date: Jan 1, 2013, End date: Dec 31, 2017,

Overcoming the barriers that the cell envelope and efflux pumps provide to Gram-negative bacteria is a major bottleneck in the discovery and development of new antibiotics. To respond to this Call we are extending our current network on antibiotic translocation and propose an ambitious project ranging from identification of novel resistance mechanisms in clinical bacterial isolates to crystallizat ...
Read Project

 28

 FINISHED 

"MOLECULAR-SCALE ELECTRONICS: Concepts, Contacts and Stability ""MOLESCO""" (MOLESCO)

Start date: Jan 1, 2014, End date: Dec 31, 2017,

"The MOLESCO network will create a unique training and research environment to develop a pool of young researchers capable of achieving breakthroughs aimed at realising the immense potential of molecular electronics. In part this will involve the major challenges of design and fabrication of molecular-scale devices. To deliver this step-change in capability, MOLESCO will coordinate the activities ...
Read Project

 10

 FINISHED 

Cold Molecular Ions at the Quantum Limit (COMIQ)

Start date: Nov 1, 2013, End date: Oct 31, 2017,

"COMIQ (COld Molecular Ions at the Quantum limit)will investigate how cooling, trapping, and control techniques applied molecular ion can expand the realm of quantum technology, enhance precision meaurements on molecular systems and lead to chemistry at the ultracold quantum limit."
Read Project

 10

 FINISHED 

Training scientists to develop and Image materials for Tissue Engineering and Regenerative Medicine (iTERM)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

The iTERM ITN (4 companies, 6 universities) will deliver 12 early stage researchers (ESR) and 1 experienced researcher (ER) trained in imaging, material science, and tissue engineering & regenerative medicine (TERM). For the aging population in the EU donor material is often not available, and artificial tissue needs to be developed to replace and repair damaged tissues. New smart materials have b ...
Read Project

 8

 FINISHED 

Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in EUrope (EU-CERT-ICD)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

An estimated 500.000 sudden cardiac deaths (SCD) occur each year in the European Union. Patients at risk for SCD may benefit from prophylactic treatment with an implantable cardioverter-defibrillator (ICD). ICD implantations have dramatically increased in recent years leading to multi-billion Euros of costs with significant regional disparities across Europe. Information on risks, benefits and cos ...
Read Project

 27

 FINISHED 

The impact of chromosomal instability on health: Molecular causes and consequences of aneuploidy (PLOIDYNET)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

Aneuploidy, an abnormal number of chromosomes, is a hallmark of cancer cells, affecting the majority of all human tumours. Aneuploidy arises when errors occur during mitosis, as the duplicated chromosomes are distributed between the two new daughter cells. Paradoxically, aneuploidy appears to have detrimental consequences for the physiology of untransformed cells in vitro, inhibiting rather than s ...
Read Project

 14

 FINISHED 

IMAging GEnetics for MENtal Disorders (IMAGEMEND)

Start date: Oct 1, 2013, End date: Sep 30, 2017,

"Mental disorders are leading causes of disability, absence from work and premature retirement in Europe. While magnetic resonance imaging (MRI) facilities are broadly available and a vast research literature exists, few neuroimaging applications have reached clinical practice in psychiatry. A major problem is that mental illnesses are currently diagnosed as discrete entities defined clinically. I ...
Read Project

 15

 FINISHED 

MOLECULAR BASIS OF ANTIBIOTIC TRANSLOCATION (Translocation)

Start date: Sep 1, 2013, End date: Aug 31, 2017,

Multidrug resistant bacteria are now ubiquitous in both hospitals and the larger community. Drug-resistant pathogens are becoming increasingly pervasive, for example, the resurrection of tuberculosis provides one ominous example highlighting the risk associated with evolved drug resistance. Moreover, many pharmaceutical companies abandoned this field and no truly novel active antibacterial compoun ...
Read Project

 11

 FINISHED 

DIAmond Devices Enabled Metrology and Sensing (DIADEMS)

Start date: Sep 1, 2013, End date: Aug 31, 2017,

The DIADEMS project aims at exploiting the unique physical properties of NV color centres in ultrapure single-crystal CVD-grown diamond to develop innovative devices with unprecedented performances for ICT applications. By exploiting the atom-like structure of the NV that exhibits spin dependent optical transitions, DIADEMS will make optics-based magnetometry possible.The objectives of DIADEMS are ...
Read Project

 17

 FINISHED 

Evolutionary dynamics of growth factor production in cancer cell populations (DUNHARROW)

Start date: Sep 1, 2014, End date: Aug 31, 2017,

Cancer is a process of clonal selection, and analytical methods from evolutionary biology should be able to explain why cancer tissues are heterogeneous and develop resistance to current therapies. Evolutionary game theory helps understand non-intuitive properties of the frequency-dependent dynamics arising in the cooperative interactions between cancer cells. In particular, the theory of N-person ...
Read Project

 2

 FINISHED 

VitaminD3-Omega3-Home Exercise- HeALTHy Ageing and Longevity Trial (DO-HEALTH)

Start date: Jan 1, 2012, End date: Jun 30, 2017,

As the European population is ageing rapidly, the growing number of seniors with age-related chronic diseases poses a challenge on European societies and health care systems. Therapeutic interventions that are effective, affordable and well-tolerated in the prevention of chronic disease are urgently needed and will have an outstanding impact on public health as a whole. Among the most promising in ...
Read Project

 25

 FINISHED 

Development of Biomaterial-based Delivery Systems for Ischemic Conditions - An Integrated Pan-European Approach (AngioMatTrain)

Start date: May 1, 2013, End date: Apr 30, 2017,

AngioMatTrain focuses on the comprehensive, multidisciplinary understanding of ischemic diseases, from basics to translation, fully supported by 8 full partners (5 universities, 1 hospital and 2 SMEs). This ITN will educate and train 12 Early Stage Researchers and 3 Experienced Researchers scientists in: tissue engineering, materials science, chemistry, functionalisation, cell biology, nanotechnol ...
Read Project

 8

 FINISHED 

Indo-European Network in Mathematics for Health and Disease (INDOEUROPEAN-MATHDS)

Start date: May 1, 2013, End date: Apr 30, 2017,

"The main aim of this proposal is to set up an Indo-European Research Network in Mathematics for Health and Disease, INDOEUROPEAN-MATHDS, that will allow the transfer of knowledge, research and training between partners. The Network will involve physicists, mathematicians, statisticians, probabilists, biologists, immunologists and engineers. The Network will create new collaborations and reinfor ...
Read Project

 7

 FINISHED 

European Autism Interventions - A Multicentre Study for Developing New Medications (EU-AIMS)

Start date: Apr 1, 2012, End date: Mar 31, 2017,

Despite dramatic advances in molecular and imaging technologies, there are currently no effective pharmacological treatments for the core symptoms of autism spectrum disorder (ASD). Major obstructions to this include a lack of aetiologically-driven or pathophysiologically-accurate animal models; an absence of tests that indicate efficacy; and reliance of clinical trials on DSM/ICD10 categories wh ...
Read Project

 29

 FINISHED 

Anticorruption Policies Revisited. Global Trends and European Responses to the Challenge of Corruption (ANTICORRP)

Start date: Mar 1, 2012, End date: Feb 28, 2017,

The central objective of ANTICORRP is to investigate and explain the factors that promote or hinder the development of effective anticorruption policies and impartial government institutions. ANTICORRP directly addresses the objective in the Work Program by examining what the causes of corruption are, how corruption can be conceptualized, measured and analysed, what the impact of corruption on s ...
Read Project

 22

 FINISHED 

Decision-making within cells and differentiation entity therapies (DECIDE)

Start date: Mar 1, 2013, End date: Feb 28, 2017,

"Our ITN has both scientific and therapeutic targets. Research in Work Package 1 (WP1) aims to advance understanding of normal blood cell development and why primitive cells fail to differentiate in acute myeloid leukaemia (AML). Research in WP2 will use the information gained from WP1 to develop ways of alleviating the differentiation block in AML and so deliver new agents for use in differentiat ...
Read Project

 8

 FINISHED 

Anti-Biopharmaceutical Immunization:Prediction and analysis of clinical relevance to minimize the risk (ABIRISK)

Start date: Mar 1, 2012, End date: Feb 28, 2017,

The ABIRISK project provides an integrated approach to the study of immunization against biopharmaceuticals, bringing together a unique panel of experts from different disciplines. ABIRISK will involve many of the European leaders in rheumatology, gastroenterology, hemophilia and multiple sclerosis, caring for ~30,000 patients treated with biopharmaceuticals, with ~10,000 additional patients recru ...
Read Project

 39

 FINISHED 

European Modular Education and Training Programme in Safety Sciences for Medicines (SAFESCIMET)

Start date: Jan 1, 2010, End date: Nov 30, 2016,

Background:In current drug safety education and training in Europe, an integrative and translational approach is lacking. This shortfall has been identified by EUFEPS. The IMI (‘Strategic Research Agenda’), the FDA and the EMEA have also characterised this fact as a crucial gap in the education and training of scientists evaluating the safety of drug candidates and new medicines. Scope and objecti ...
Read Project

 34